Aberdeen Group plc lifted its holdings in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 5,532.7% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 278,197 shares of the medical equipment provider's stock after acquiring an additional 273,258 shares during the period. Aberdeen Group plc owned 0.39% of Align Technology worth $44,720,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in the business. Assenagon Asset Management S.A. grew its position in shares of Align Technology by 638.7% during the third quarter. Assenagon Asset Management S.A. now owns 4,662,437 shares of the medical equipment provider's stock valued at $629,469,000 after purchasing an additional 4,031,284 shares in the last quarter. BlackRock Inc. purchased a new stake in shares of Align Technology in the second quarter worth about $745,370,000. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lifted its position in shares of Align Technology by 3,162.7% in the third quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,097,745 shares of the medical equipment provider's stock worth $278,342,000 after buying an additional 2,033,451 shares in the last quarter. Vontobel Holding Ltd. grew its holdings in Align Technology by 69,628.9% during the 3rd quarter. Vontobel Holding Ltd. now owns 1,385,513 shares of the medical equipment provider's stock valued at $183,335,000 after buying an additional 1,383,526 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its stake in Align Technology by 4.9% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 1,054,633 shares of the medical equipment provider's stock worth $180,796,000 after acquiring an additional 49,220 shares during the last quarter. Hedge funds and other institutional investors own 88.43% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts have recently issued reports on the company. UBS Group reaffirmed a "neutral" rating and set a $189.00 price objective on shares of Align Technology in a report on Thursday, July 23rd. Evercore downgraded Align Technology from an "outperform" rating to an "in-line" rating and set a $155.00 target price for the company. in a research report on Monday, October 5th. Leerink Partners cut their target price on shares of Align Technology from $235.00 to $215.00 and set an "outperform" rating for the company in a report on Wednesday, October 14th. Robert W. Baird cut shares of Align Technology from an "outperform" rating to a "neutral" rating and reduced their price target for the stock from $218.00 to $162.00 in a research report on Thursday, October 15th. Finally, Stifel Nicolaus reduced their price target on shares of Align Technology from $210.00 to $175.00 and set a "buy" rating on the stock in a research report on Friday, October 9th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $193.08.
Get Our Latest Report on Align Technology
Align Technology Price Performance
NASDAQ ALGN opened at $168.32 on Monday. The company has a fifty day moving average of $151.67 and a two-hundred day moving average of $168.57. The firm has a market capitalization of $11.86 billion, a price-to-earnings ratio of 24.50, a PEG ratio of 2.18 and a beta of 1.74. Align Technology, Inc. has a 52 week low of $130.23 and a 52 week high of $200.43.
Align Technology (NASDAQ:ALGN - Get Free Report) last announced its earnings results on Wednesday, October 28th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.77 by $0.03. The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1 billion. Align Technology had a net margin of 11.83% and a return on equity of 15.96%. The business's revenue for the quarter was up 1.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.61 earnings per share. Equities research analysts anticipate that Align Technology, Inc. will post 9.21 EPS for the current year.
Align Technology Profile
(
Free Report)
Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Align Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.
While Align Technology currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.